Heart Safety Study of Ondansetron in Children Receiving Chemotherapy
Status:
Withdrawn
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
We will study the effects of ondansetron on measurements of electrical activity in the heart
to make sure doses we are using to prevent nausea and vomiting in children receiving
chemotherapy are safe.